NSEGeneral Updates11 Aug 2026 · 11 Aug 2026, 05:47 pm

General Updates

Fischer Medical Ventures Limited · FISCHER

✦ AI SummaryFundraise

Fischer Medical Ventures Limited has informed the Exchange about the allotment of 23,00,000 (Twenty Three Lakhs) Equity Shares upon exercising the option available with the Share Warrant Holder to convert 23,00,000 (Twenty Three Lakhs) Convertible Warrants. The allotment has been made for cash at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) (including a premium of Rs. 22.40 per share) upon the receipt of the remaining exercise price of Rs. 17.55/- per warrant aggregating to Rs. 4,03,65,000/- (Rupees Four Crores Three Lakhs Sixty Five Thousand Only).

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Fischer Medical Ventures Limited has informed the Exchange about allotment of Equity shares pursuant to conversion of warrants

Attachments (1)

📄

FISCHER_11082026174541_INTIREG30.pdf

pdf

Download →
View document text
FISCHER MEDICAL VENTURES LIMITED Registered Office Address: Survey No. 480/2 AP Medtech Zone, Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032 CIN: L86900AP1993PLC118162 Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548 August 11, 2026 To To BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, 5tll floor, 25th Floor, P J Towers, Plot No. C/ 1, G Block, Dalal Street, Fort, Bandra-Kurla Complex Bandra (E), Mumbai – 400 001. Mumbai - 400 051. BSE Scrip Code: 524743 NSE Symbol: FISCHER Dear Sir/ Madam, Sub: : Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Conversion of warrants into equity shares. Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions if any, we hereby inform you that the Board of Directors of the Company through Circular Resolution dated today i.e., Tuesday, 11th August, 2026, approved the allotment of 23,00,000 (Twenty Three Lakhs) Equity Shares having Face value of Re. 1/- each at an issue price of Rs. 23.40/- (Rupees Twenty Three and Forty Paise Only) (including a premium of Rs. 22.40 per share) fully paid up upon exercising the option available with the Share Warrant Holder (person belonging to Promoter Category) to convert 23,00,000 (Twenty Three Lakhs) Convertible Warrants. The allotment has been made for cash, upon the receipt of the remaining exercise price of Rs. 17.55/- per warrant (being an equivalent amount to 75% of the Warrant exercise price of Rs. 23.40/- per warrant) aggregating to Rs. 4,03,65,000/- (Rupees Four Crores Three Lakhs Sixty Five Thousand Only). In this regard, the details of the allottee and number of warrants converted are hereby mentioned. S.No Name of the Allottee Category (Promoter/ No. of Warrants converted into Total Consideration Non-promoter) Equity Shares Received (75%)( Rs.) 1 Mr. Shankar Promoter 23,00,000 4,03,65,000 Varadharajan Total 23,00,000 4,03,65,000 Thanking you, Yours Truly, For FISCHER MEDICAL VENTURES LIMITED BALAJI GANDLA COMPANY SECRETARY AND COMPLIANCE OFFICER Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006